Two Sigma Investments, LP Castle Biosciences Inc Transaction History

Two Sigma Investments, LP

  • $50.6 Billion
  • Q2 2025

A detailed history of Two Sigma Investments, LP transactions in Castle Biosciences Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 28,241 shares of CSTL stock, worth $642,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,241
Previous 139,785 79.8%
Holding current value
$642,482
Previous $2.8 Million 79.41%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$15.8 - $21.98 $1.76 Million - $2.45 Million
-111,544 Reduced 79.8%
28,241 $576,000
Q1 2025

May 15, 2025
BUY
$18.76 - $32.72 $2.62 Million - $4.57 Million
139,785 New
139,785 $2.8 Million
Q3 2024

Nov 14, 2024
SELL
$17.4 - $31.47 $121,799 - $220,290
-7,000 Reduced 41.67%
9,800 $279,000
Q2 2024

Aug 14, 2024
BUY
$18.84 - $24.94 $1,884 - $2,494
100 Added 0.6%
16,800 $365,000
Q1 2024

May 15, 2024
SELL
$18.06 - $25.3 $10,836 - $15,180
-600 Reduced 3.47%
16,700 $369,000
Q4 2023

Feb 14, 2024
BUY
$12.19 - $22.43 $54,855 - $100,935
4,500 Added 35.16%
17,300 $373,000
Q3 2023

Nov 14, 2023
SELL
$13.28 - $20.3 $253,648 - $387,730
-19,100 Reduced 59.87%
12,800 $216,000
Q2 2023

Aug 14, 2023
BUY
$11.66 - $26.0 $108,158 - $241,176
9,276 Added 41.0%
31,900 $437,000
Q1 2023

May 15, 2023
SELL
$19.47 - $28.49 $609,819 - $892,335
-31,321 Reduced 58.06%
22,624 $514,000
Q4 2022

Feb 14, 2023
SELL
$18.08 - $30.0 $1.22 Million - $2.03 Million
-67,603 Reduced 55.62%
53,945 $1.27 Million
Q3 2022

Nov 14, 2022
SELL
$22.51 - $34.32 $627,601 - $956,875
-27,881 Reduced 18.66%
121,548 $3.17 Million
Q2 2022

Aug 15, 2022
BUY
$16.0 - $45.99 $2.39 Million - $6.87 Million
149,429 New
149,429 $3.28 Million
Q1 2022

May 16, 2022
SELL
$33.17 - $46.98 $4.49 Million - $6.36 Million
-135,367 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$39.06 - $67.58 $2.44 Million - $4.22 Million
62,401 Added 85.52%
135,367 $5.8 Million
Q3 2021

Nov 15, 2021
BUY
$60.13 - $77.6 $1.81 Million - $2.33 Million
30,028 Added 69.93%
72,966 $4.85 Million
Q2 2021

Aug 16, 2021
SELL
$50.07 - $76.78 $2.47 Million - $3.78 Million
-49,286 Reduced 53.44%
42,938 $3.15 Million
Q1 2021

May 17, 2021
BUY
$58.92 - $97.33 $1.32 Million - $2.18 Million
22,409 Added 32.1%
92,224 $6.31 Million
Q4 2020

Feb 16, 2021
BUY
$43.6 - $73.05 $2.86 Million - $4.79 Million
65,615 Added 1562.26%
69,815 $4.69 Million
Q3 2020

Nov 16, 2020
SELL
$38.47 - $52.03 $994,526 - $1.35 Million
-25,852 Reduced 86.02%
4,200 $216,000
Q2 2020

Aug 14, 2020
BUY
$27.28 - $43.01 $819,818 - $1.29 Million
30,052 New
30,052 $1.13 Million

Others Institutions Holding CSTL

# of Institutions
165
Shares Held
27.2M
Call Options Held
0
Put Options Held
0
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $598M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email